SHARP: Personalized Health and Behavior Plan to Lower Biological Age in Older Adults
Official title: Sheba Healthspan Research Population (SHARP) Trial
Run by Sheba Medical Center · NCT07596576 · Data updated 2026-11-12
A 12-month randomized trial tests whether a personalized health and behavior program can lower biological age and improve function in healthy adults over 50.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 1500 (estimated) |
| Sponsor | Sheba Medical Center Government |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Ramat Gan, Tel Aviv) |
| Status | Recruiting |
| Started | March 1, 2024 |
| Main results expected | March 1, 2027 |
| Study ends | December 1, 2027 |
| Registry record updated | May 19, 2026 |
| Trial ID | NCT07596576 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Healthy men and women over 50 who live in the community and can attend study visits.
✕Probably not a fit
Individuals with significant cognitive impairment, neurodegenerative disease, psychiatric illness, or recent cancer therapy may not benefit from the intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study randomizes healthy community-dwelling adults over 50 to receive a personalized health and behavioral intervention based on an integrative systems approach, with biomarker and functional outcomes tracked at baseline, 6 months, and 12 months. Participants in the intervention group are guided by a tailored plan and monitored through a purpose-built app to track adherence and physiology. Comprehensive baseline and follow-up assessments include metabolic lab work, immune and hormonal panels, microbiome and proteomics analyses, physical and imaging measures, cognitive and mental health evaluations, and lifestyle data. Primary endpoints focus on changes in biological aging markers, while secondary endpoints assess functional and cognitive performance.
Why it matters
Potential benefit: If successful, the program could slow aspects of biological aging and support better physical and cognitive function in older adults.
How similar studies have gone: Prior research in aging and lifestyle interventions has shown potential to influence biomarkers of aging, but results vary and this study evaluates a comprehensive, personalized protocol.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy older adults \>50 years old men and women Exclusion Criteria: 1. A former diagnostic of a significant cognitive reduction (MoCa score \< 24 ). 2. Former diagnosis of neurodegenerative disease as Alzheimer's disease, Parkinson's disease, Lewy body dementia. 3. Former diagnosis of psychiatric disease. 4. In the past two years, underwent chemotherapy or radiation therapy.
Where it's running
-
Sheba Medical Center
Ramat Gan, Tel Aviv, Israel Recruiting
Study contacts
- Principal investigator: Evelyne Bischof, MD PhD — Sheba Medical Center
- Study coordinator: tzipi strauss, MD
- Email: zipora.strauss@sheba.heath.gov.il
- Phone: 972526664446
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Personalized multidomain care pathway for older adults with Intrinsic Capacity decline
This study tests a personalized, ICOPE-based multidomain care plan for community-dwelling adults aged 65 and older to see if a 6-month program can be completed and sustained.
-
Do Quercefit® or Ubiqsome™ help with aging and metabolic health in adults 50–75?
This study tests whether Quercefit® or Ubiqsome™ can improve aging markers, blood sugar, and heart health in sedentary adults aged 50–75 compared with a placebo.
-
NVTIA Ergothioneine for Healthy Aging and Skin Health
This study tests whether taking NVTIA Ergothioneine daily for 12 weeks helps healthy adults age more gracefully and keeps skin looking and feeling better compared with a placebo.
-
Miricell supplementation and markers of healthy aging
This trial tests whether taking Miricell once daily for 12 weeks improves cellular health and brain/metabolic indicators in adults aged 40–70 compared with a placebo.
-
Does daily lean beef support brain health in older adults
In healthy adults aged 65 and up, this study tests whether eating lean beef every day for two weeks can influence brain health markers compared with a non-beef, protein-matched option.
-
Adaptive computerized training to boost thinking in healthy seniors and those with mild cognitive impairment
This study tests whether a computer-based training program can improve executive thinking in older adults, including those with mild cognitive impairment, and see if it also helps memory and well-being.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.